With a market capitalization (market cap) of $1.29B — a measure of how much the company is worth — Alpha Tau Medical Ltd is the 2420th most valuable company in Healthcare as of August 18, 2026. Shares trade at $14.26, up +0.78% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Visit websiteAs of August 18, 2026, Alpha Tau Medical Ltd (DRTS) is worth $1.29B — this is its market capitalization, the total value of all its outstanding shares.
Alpha Tau Medical Ltd’s market cap is $1.29B, which ranks it #2420 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Alpha Tau Medical Ltd (DRTS) shares trade at $14.26, up 0.78% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025